Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F.

Lancet Neurol. 2019 Jul 17. pii: S1474-4422(19)30244-3. doi: 10.1016/S1474-4422(19)30244-3. [Epub ahead of print] Review.

PMID:
31326280
2.

Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.

Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Ribas IG, Desideri S, Ye X; Adult Brain Tumor Consortium.

Clin Cancer Res. 2019 Jan 1;25(1):73-79. doi: 10.1158/1078-0432.CCR-18-0110. Epub 2018 Aug 21.

PMID:
30131387
3.

Paraneoplastic Neurologic Syndromes.

Rosenfeld MR, Dalmau J.

Neurol Clin. 2018 Aug;36(3):675-685. doi: 10.1016/j.ncl.2018.04.015. Epub 2018 Jun 18. Review.

PMID:
30072076
4.

Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.

Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, Llufriu S, Muchart J, Erro ME, Abraira L, Moris G, Monros-Giménez L, Corral-Corral Í, Montejo C, Toledo M, Bataller L, Secondi G, Ariño H, Martínez-Hernández E, Juan M, Marcos MA, Alsina L, Saiz A, Rosenfeld MR, Graus F, Dalmau J; Spanish Herpes Simplex Encephalitis Study Group.

Lancet Neurol. 2018 Sep;17(9):760-772. doi: 10.1016/S1474-4422(18)30244-8. Epub 2018 Jul 23.

5.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

6.

Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Hara M, Martinez-Hernandez E, Ariño H, Armangué T, Spatola M, Petit-Pedrol M, Saiz A, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 Apr 17;90(16):e1386-e1394. doi: 10.1212/WNL.0000000000005329. Epub 2018 Mar 16.

7.

Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy-Detecting Elusive Disease, Defining Response.

New PZ, Rosenfeld MR.

Front Neurol. 2017 Jul 3;8:311. doi: 10.3389/fneur.2017.00311. eCollection 2017. No abstract available.

8.

DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

Hara M, Ariño H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2017 Apr 4;88(14):1340-1348. doi: 10.1212/WNL.0000000000003796. Epub 2017 Mar 3.

9.

Investigations in GABAA receptor antibody-associated encephalitis.

Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo Artigues MI, Julià Benique MR, Benson L, Gorman M, Felipe A, Caparó Oblitas RL, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2017 Mar 14;88(11):1012-1020. doi: 10.1212/WNL.0000000000003713. Epub 2017 Feb 15.

10.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

11.

Update on neurological paraneoplastic syndromes.

Höftberger R, Rosenfeld MR, Dalmau J.

Curr Opin Oncol. 2015 Nov;27(6):489-95. doi: 10.1097/CCO.0000000000000222. Review.

12.

Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.

Blakeley JO, Grossman SA, Mikkelsen T, Rosenfeld MR, Peereboom D, Nabors LB, Chi AS, Emmons G, Garcia Ribas I, Supko JG, Desideri S, Ye X.

J Neurooncol. 2015 Oct;125(1):123-31. doi: 10.1007/s11060-015-1876-0. Epub 2015 Aug 19.

13.

Antibody-mediated central nervous system diseases: disease recognition and treatment challenges.

Rosenfeld MR.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:30-2. doi: 10.1111/cei.12501. No abstract available.

14.

Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.

Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J.

JAMA Neurol. 2015 Feb;72(2):180-6. doi: 10.1001/jamaneurol.2014.2956.

15.

Neuronal surface antibody-mediated autoimmune encephalitis.

Linnoila JJ, Rosenfeld MR, Dalmau J.

Semin Neurol. 2014 Sep;34(4):458-66. doi: 10.1055/s-0034-1390394. Epub 2014 Nov 4. Review.

16.

Reply: To PMID 24700511.

Titulaer MJ, Rosenfeld MR, Dalmau J.

Ann Neurol. 2014 Sep;76(3):464-5. doi: 10.1002/ana.24223. Epub 2014 Jul 26. No abstract available.

PMID:
25043899
17.

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, Mikkelson T, Wang D, Chang YC, Hu J, McAfee Q, Fisher J, Troxel AB, Piao S, Heitjan DF, Tan KS, Pontiggia L, O'Dwyer PJ, Davis LE, Amaravadi RK.

Autophagy. 2014 Aug;10(8):1359-68. doi: 10.4161/auto.28984. Epub 2014 May 20.

18.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J.

Ann Neurol. 2014 Mar;75(3):411-28.

19.

Autoimmune encephalitis update.

Dalmau J, Rosenfeld MR.

Neuro Oncol. 2014 Jun;16(6):771-8. doi: 10.1093/neuonc/nou030. Epub 2014 Mar 16. Review.

20.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J.

Lancet Neurol. 2014 Feb;13(2):167-77. doi: 10.1016/S1474-4422(13)70282-5. Epub 2013 Dec 18. Erratum in: Lancet Neurol. 2014 Feb;13(2):135.

21.

Neurological complications of solid organ transplantation.

Pruitt AA, Graus F, Rosenfeld MR.

Neurohospitalist. 2013 Jul;3(3):152-66. doi: 10.1177/1941874412466090.

22.

Neurological complications of transplantation: part I: hematopoietic cell transplantation.

Pruitt AA, Graus F, Rosenfeld MR.

Neurohospitalist. 2013 Jan;3(1):24-38. doi: 10.1177/1941874412455338.

23.

Late-onset anti-NMDA receptor encephalitis.

Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L, Torrents A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J.

Neurology. 2013 Sep 17;81(12):1058-63. doi: 10.1212/WNL.0b013e3182a4a49c. Epub 2013 Aug 14.

24.

Diagnosis and management of paraneoplastic neurologic disorders.

Rosenfeld MR, Dalmau J.

Curr Treat Options Oncol. 2013 Dec;14(4):528-38. doi: 10.1007/s11864-013-0249-1. Review.

25.

Bridging science and clinical practice: how to use molecular markers when caring for a patient with brain cancer.

Rosenfeld MR.

Am Soc Clin Oncol Educ Book. 2013:108-13. doi: 10.1200/EdBook_AM.2013.33.108. Review.

26.

Paraneoplastic syndromes and autoimmune encephalitis: Five new things.

Rosenfeld MR, Titulaer MJ, Dalmau J.

Neurol Clin Pract. 2012 Sep;2(3):215-223.

27.

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.

Norden AD, Lesser GJ, Drappatz J, Ligon KL, Hammond SN, Lee EQ, Reardon DR, Fadul CE, Plotkin SR, Batchelor TT, Zhu JJ, Beroukhim R, Muzikansky A, Doherty L, Lafrankie D, Smith K, Tafoya V, Lis R, Stack EC, Rosenfeld MR, Wen PY.

Neuro Oncol. 2013 Jul;15(7):930-5. doi: 10.1093/neuonc/not040. Epub 2013 Apr 3.

28.

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.

Villano JL, Wen PY, Lee EQ, Nayak L, Reardon DA, Rosenfeld MR.

J Neurooncol. 2013 May;113(1):143-7. doi: 10.1007/s11060-013-1100-z. Epub 2013 Mar 12. No abstract available.

PMID:
23479035
29.

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

Peereboom DM, Ahluwalia MS, Ye X, Supko JG, Hilderbrand SL, Phuphanich S, Nabors LB, Rosenfeld MR, Mikkelsen T, Grossman SA; New Approaches to Brain Tumor Therapy Consortium.

Neuro Oncol. 2013 Apr;15(4):490-6. doi: 10.1093/neuonc/nos322. Epub 2013 Jan 17.

30.

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J.

Lancet Neurol. 2013 Feb;12(2):157-65. doi: 10.1016/S1474-4422(12)70310-1. Epub 2013 Jan 3.

31.

Paraneoplastic Neurologic Disorders: A Brief Overview.

Rosenfeld MR, Dalmau J.

Memo. 2012 Sep 1;5(3):197-200. Epub 2012 Jul 6.

32.

Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J.

Ann Neurol. 2013 Jan;73(1):120-8. doi: 10.1002/ana.23756. Epub 2012 Dec 7.

33.

Management of malignant gliomas and primary CNS lymphoma: standard of care and future directions.

Rosenfeld MR, Pruitt AA.

Continuum (Minneap Minn). 2012 Apr;18(2):406-15. doi: 10.1212/01.CON.0000413666.88539.0b. Review.

PMID:
22810135
34.

Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.

Rosenfeld MR, Dalmau JO.

Continuum (Minneap Minn). 2012 Apr;18(2):366-83. doi: 10.1212/01.CON.0000413664.42798.aa. Review.

PMID:
22810133
35.

A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306).

Nabors LB, Mikkelsen T, Hegi ME, Ye X, Batchelor T, Lesser G, Peereboom D, Rosenfeld MR, Olsen J, Brem S, Fisher JD, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT) Central Nervous System Consortium.

Cancer. 2012 Nov 15;118(22):5601-7. doi: 10.1002/cncr.27585. Epub 2012 Apr 19.

36.

Phase I study of terameprocol in patients with recurrent high-grade glioma.

Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S; Adult Brain Tumor Consortium.

Neuro Oncol. 2012 Apr;14(4):511-7. doi: 10.1093/neuonc/nor230. Epub 2012 Feb 8.

37.

Central nervous system paraneoplastic disease.

Rosenfeld MR, Dalmau J.

Handb Clin Neurol. 2012;105:853-64. doi: 10.1016/B978-0-444-53502-3.00027-6. Review. No abstract available.

PMID:
22230537
38.

Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature.

Sanborn MR, Danish SF, Rosenfeld MR, O'Rourke D, Lee JY.

Clin Neurol Neurosurg. 2011 Nov;113(9):798-802. doi: 10.1016/j.clineuro.2011.08.007. Epub 2011 Sep 8. No abstract available.

PMID:
21906869
39.

Update on paraneoplastic neurologic disorders.

Dalmau J, Rosenfeld MR.

Community Oncol. 2010 May 1;7(5):219-224.

40.

Paraneoplastic syndromes causing movement disorders.

Dalmau J, Rosenfeld MR.

Handb Clin Neurol. 2011;100:315-21. doi: 10.1016/B978-0-444-52014-2.00024-0. Review.

PMID:
21496591
41.

Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders.

Rosenfeld MR, Dalmau J.

Curr Treat Options Neurol. 2011 Jun;13(3):324-32. doi: 10.1007/s11940-011-0116-y.

42.

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R.

Lancet Neurol. 2011 Jan;10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2. Review.

43.

Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas.

Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR.

Neurologia. 2011 Mar;26(2):74-80. doi: 10.1016/j.nrl.2010.05.010. Epub 2010 Nov 3. English, Spanish.

44.

[Differential diagnosis of encephalitis due to anti-NMDA receptor antibodies].

González-Valcárcel J, Rosenfeld MR, Dalmau J.

Neurologia. 2010 Sep;25(7):409-13. Spanish.

45.

A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.

Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X.

Neuro Oncol. 2010 Oct;12(10):1071-7. doi: 10.1093/neuonc/noq071. Epub 2010 Jul 8.

46.

Update on paraneoplastic and autoimmune disorders of the central nervous system.

Rosenfeld MR, Dalmau J.

Semin Neurol. 2010 Jul;30(3):320-31. doi: 10.1055/s-0030-1255223. Epub 2010 Jun 24. Review.

PMID:
20577938
47.

Update on paraneoplastic neurologic disorders.

Rosenfeld MR, Dalmau J.

Oncologist. 2010;15(6):603-17. doi: 10.1634/theoncologist.2010-0001. Epub 2010 May 17.

48.

Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma.

Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J.

Acta Neuropathol. 2009 Dec;118(6):737-43. doi: 10.1007/s00401-009-0582-4.

49.

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J.

Ann Neurol. 2009 Jul;66(1):11-8. doi: 10.1002/ana.21756.

50.

Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.

Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, Kaplan DE, Chang KM, Domchek SM, Kanetsky PA, Fecher LA, Flaherty KT, Schuchter LM, Vonderheide RH.

Clin Cancer Res. 2009 Jul 1;15(13):4277-87. doi: 10.1158/1078-0432.CCR-09-0537. Epub 2009 Jun 23.

Supplemental Content

Loading ...
Support Center